These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 2860433

  • 1. MOPP chemotherapy alone: a suitable treatment for early stages of Hodgkin's disease?
    Colonna P, Andrieu JM.
    Lancet; 1985 May 25; 1(8439):1224. PubMed ID: 2860433
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [MOPP therapy of Hodgkin's disease previously treated with MOPP].
    Frau A, Montalar J.
    Med Clin (Barc); 1985 May 18; 84(19):801. PubMed ID: 3839875
    [No Abstract] [Full Text] [Related]

  • 4. Should MOPP-ABVD alone be standard for childhood Hodgkin's?
    Constine LS.
    J Clin Oncol; 1998 Mar 18; 16(3):1235. PubMed ID: 9508214
    [No Abstract] [Full Text] [Related]

  • 5. [Prognostic value of the results of short-term polychemotherapy by the MOPP program of Hodgkin's disease stages III and IV].
    Hansz J, Burchardt K, Komarnicki M, Trepińska E, Psuja P.
    Pol Arch Med Wewn; 1984 Dec 18; 72(6):293-8. PubMed ID: 6549512
    [No Abstract] [Full Text] [Related]

  • 6. [Results of the treatment of patients with Hodgkin's disease by the MOPP protocol in relation to the histological type of the disease].
    Krajewska B, Dziewulska-Bokiniec A, Goszczyńska-Matysiak E, Kacprzak G.
    Nowotwory; 1987 Dec 18; 37(4):317-21. PubMed ID: 3451197
    [No Abstract] [Full Text] [Related]

  • 7. [Hodgkin's lymphoma in children: results of treatment with the MOPP protocol and a combination of radiotherapy and chemotherapy].
    Vuković I, Janković MB, Janić D, Stojimirović E.
    Srp Arh Celok Lek; 1985 Dec 18; 113(11-12):1013-21. PubMed ID: 3841764
    [No Abstract] [Full Text] [Related]

  • 8. The role of dose and rate of administration of MOPP drugs in 97 retrospective Hodgkin's patients.
    Gobbi PG, Cavalli C, Rossi A, Bertoloni D, Galeone F, Pieresca C, Grignani E.
    Haematologica; 1987 Dec 18; 72(6):523-8. PubMed ID: 3126109
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Chemotherapy alone for the treatment of early-stage Hodgkin's disease.
    Cimino G.
    Eur J Cancer; 1990 Dec 18; 26(11-12):1115-8. PubMed ID: 2149991
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of MOPP/MOPP +/- RT vs. MOPp/ABVD +/- RT in poor prognosis Hodgkin's disease. Long-term results.
    Comella P, Abate G, Fiore M, Di Finizio G, Frezza P, Scoppa G, Anania C, Coucourde F, Zarrilli D.
    J Chemother; 1989 Jul 18; 1(4 Suppl):1254-6. PubMed ID: 16312855
    [No Abstract] [Full Text] [Related]

  • 15. Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.
    Fermé C, Eghbali H, Meerwaldt JH, Rieux C, Bosq J, Berger F, Girinsky T, Brice P, van't Veer MB, Walewski JA, Lederlin P, Tirelli U, Carde P, Van den Neste E, Gyan E, Monconduit M, Diviné M, Raemaekers JM, Salles G, Noordijk EM, Creemers GJ, Gabarre J, Hagenbeek A, Reman O, Blanc M, Thomas J, Vié B, Kluin-Nelemans JC, Viseu F, Baars JW, Poortmans P, Lugtenburg PJ, Carrie C, Jaubert J, Henry-Amar M, EORTC-GELA H8 Trial.
    N Engl J Med; 2007 Nov 08; 357(19):1916-27. PubMed ID: 17989384
    [Abstract] [Full Text] [Related]

  • 16. [Late results of the treatment of advanced Hodgkin's disease by the MOPP/COPP programs (chlormethine or cyclophosphamide, vincristine, procarbazine and prednisone)].
    Błasińska-Morawiec M, Płuzańska A, Krykowski E, Robak T, Mrówka I.
    Pol Arch Med Wewn; 1991 Oct 08; 86(4):274-80. PubMed ID: 1813880
    [Abstract] [Full Text] [Related]

  • 17. Is ABVD the standard regimen for Hodgkin's disease based on randomized CALGB comparison of MOPP, ABVD and MOPP alternating with ABVD?
    Canellos GP.
    Leukemia; 1996 Jun 08; 10 Suppl 2():s68. PubMed ID: 8649055
    [No Abstract] [Full Text] [Related]

  • 18. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E, Anselmo AP, Klersy C, Santoro M, Orlandi E, Pagnucco G, Lunghi F, Maurizi-Enrici R, Baroni CD, Lazzarino M, Mandelli F, Bernasconi C.
    Haematologica; 1998 Sep 08; 83(9):812-23. PubMed ID: 9825578
    [Abstract] [Full Text] [Related]

  • 19. British National Lymphoma Investigation randomised study of MOPP (mustine, Oncovin, procarbazine, prednisolone) against LOPP (Leukeran substituted for mustine) in advanced Hodgkin's disease--long term results.
    Hancock BW, Vaughan Hudson G, Vaughan Hudson B, Haybittle JL, Bennett MH, MacLennan KA, Jelliffe AM.
    Br J Cancer; 1991 Apr 08; 63(4):579-82. PubMed ID: 2021542
    [Abstract] [Full Text] [Related]

  • 20. Radiation therapy versus combination chemotherapy in the treatment of early-stage Hodgkin's disease: seven-year results of a prospective randomized trial.
    Longo DL, Glatstein E, Duffey PL, Young RC, Hubbard SM, Urba WJ, Wesley MN, Raubitschek A, Jaffe ES, Wiernik PH.
    J Clin Oncol; 1991 Jun 08; 9(6):906-17. PubMed ID: 2033427
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.